NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Spotlight: Stocks Steal the Show on May 8

In a market short on fresh triggers, several stocks quietly stole the spotlight on May 8, driven purely by price action, technical breakouts, and sustained buying momentum.

The selected stocks are showing strong upward momentum, trading well above their key short- to medium-term moving averages, which indicates a positive trend in the near term.

Sagardeep Alloy was trading at Rs 26.70, up 11.81% during the session. The stock is trading above its 30-day SMA of 23.88 and 50-day SMA of 23.44, suggesting strong near-term momentum. However, it remains slightly above the 150-day SMA of 25.46 and close to the 200-day SMA of 26.05, indicating improving long-term strength as well.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Grand Continent gained 7.48% to trade at Rs 104.60. The stock is trading comfortably above its 30-day SMA of 97.32 and 50-day SMA of 94.97, reflecting sustained buying interest in the short term. However, it is still below its 150-day SMA of 138.04 and 200-day SMA of 151.45, which may indicate that the broader long-term trend remains weak despite the recent recovery.

Solex Energy advanced 5.93% to Rs 1,377.10 and showed strong bullish momentum across all major moving averages. The stock is trading above its 30-day SMA of 1,300.01, 50-day SMA of 1,165.05, 150-day SMA of 1,270.13, and 200-day SMA of 1,310.57. This indicates strong upward momentum and continued investor confidence across both short- and long-term time frames.

In contrast, other stocks are witnessing downward pressure, as reflected in negative price movements and their positioning relative to key moving averages, indicating a cautious market sentiment.

TruAlt Bioenerg was trading at Rs 432.60, down 6.50% during the session. The stock is trading below its 30-day SMA of 462.69, indicating weak short-term momentum. However, it remains close to its 50-day SMA of 436.60 and above its 150-day SMA of 423.50, suggesting that the longer-term trend is relatively stable despite recent selling pressure.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Prostarm Info declined 4.70% to Rs 146.25. The stock is trading below its 30-day SMA of 153.47 as well as its 150-day SMA of 158.61 and 200-day SMA of 170.46, reflecting weakness in both short- and long-term trends. However, it remains slightly above the 50-day SMA of 143.21, which indicates that near-term support may still be intact.

HVAX Technologies slipped 4.11% to Rs 776. The stock is trading below all major moving averages, including the 30-day SMA of 809.29, 150-day SMA of 826.03, and 200-day SMA of 817.52. This suggests sustained bearish sentiment and continued weakness across short-, medium-, and long-term periods.

A few stocks saw sharp intraday moves and hit upper circuits. Venus Remedies, Modison, Gujarat Raffia Industries, and GE Power India were locked in the upper band, reflecting strong demand and limited supply—often a sign of bullish near-term sentiment.

Meanwhile, a broad set of stocks scaled fresh 52-week highs, underscoring resilient underlying demand despite the absence of major news catalysts.

Notable gainers included:

StockGain
HFCL
Torrent Pharma
JB Chemicals
Angel One
Gland Pharma
Vodafone Idea
Navin Fluorine
Bajaj Auto
GE Vernova TD

Investor Takeaway

Investors should consider stocks with strong upward momentum and sustained buying interest.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.